miRNA Sequencing & Assay Market by Product Type, Technology, Sample Type, Application, End User

The miRNA Sequencing & Assay Market is projected to reach USD 502.41 Million in 2026. It is expected to continue growing at a CAGR of 14.55%, reaching USD 1.12 Billion by 2032.

miRNA sequencing and assay technologies are becoming core tools for biomarker discovery, translational medicine, oncology research, cardiovascular studies, neurology, reproductive health, and infectious disease profiling. MicroRNAs are short, non-coding RNA molecules, typically about 18 to 24 nucleotides, that regulate gene expression after transcription and are measurable in tissue, blood, plasma, serum, extracellular vesicles, and other biofluids.

The market is supported by the convergence of next-generation sequencing, qPCR-based miRNA assays, digital PCR, sample preparation automation, and bioinformatics pipelines. Reference resources such as miRBase release 22.1, which catalogs more than 38,000 hairpin precursors and over 48,000 mature microRNA products across species, and large-scale programs such as The Cancer Genome Atlas have strengthened the scientific foundation for microRNA expression analysis. Demand is increasing as life science companies, clinical laboratories, and academic research centers seek reproducible, high-sensitivity approaches for non-invasive biomarker validation and precision medicine workflows.

Transformative Shifts in the miRNA Sequencing Landscape

The miRNA sequencing and assay landscape is shifting from exploratory discovery toward clinically oriented validation. Small RNA sequencing remains essential for unbiased discovery of known and novel miRNAs, while targeted qPCR panels and digital PCR are increasingly used for confirmation, low-input samples, and high-throughput screening. This creates a workflow in which sequencing identifies candidates and assay platforms translate those candidates into scalable biomarkers.

Another major shift is the move from tissue-centric analysis to liquid biopsy and extracellular vesicle-based research. Because miRNAs are relatively stable in circulation and can be packaged in exosomes, microvesicles, or protein complexes, they are being evaluated as minimally invasive indicators of disease state, therapy response, and recurrence risk. At the same time, laboratories are standardizing RNA extraction, library preparation, normalization, and data interpretation to address pre-analytical variability, including hemolysis, storage conditions, RNA input quantity, and platform-specific bias, that can affect miRNA measurements.

Cumulative Impact of Artificial Intelligence on miRNA Analysis

Artificial intelligence is improving miRNA sequencing and assay workflows by supporting read quality assessment, adapter trimming, feature selection, differential expression analysis, target prediction, pathway enrichment, and multi-omics integration. AI-enabled models are especially useful in separating disease-linked miRNA signatures from biological noise, batch effects, hemolysis-related artifacts, and sample-handling variation.

In clinical research, machine learning is being used to combine miRNA expression with genomics, transcriptomics, proteomics, imaging, electronic health records, and treatment outcomes. This strengthens biomarker panels by identifying combinations of miRNAs that may outperform single-analyte markers. However, AI adoption requires transparent model validation, explainability, external cohort testing, and data governance. For regulated diagnostics, AI-derived miRNA signatures must be reproducible across instruments, laboratories, populations, and specimen types before they can support clinical decision-making.

Key Regional Insights for miRNA Sequencing & Assays

Asia-Pacific is a high-growth center for miRNA sequencing and assay adoption, supported by major genomics investments in China, Japan, South Korea, India, and Australia. China’s large sequencing capacity, expanding hospital-based molecular testing, and national precision medicine priorities are strengthening small RNA sequencing and biomarker research. Japan’s aging-population research priorities, India’s expanding biotechnology ecosystem and clinical trial base, South Korea’s precision medicine programs, and Australia’s clinical genomics initiatives are collectively increasing regional demand for miRNA assays, liquid biopsy research, and translational biomarker validation.

North America remains a leading hub due to federally funded biomedical research, advanced clinical laboratory infrastructure, CLIA-oriented testing environments, biopharma R&D, and strong adoption of NGS platforms. Europe benefits from robust academic networks, Horizon Europe funding, national genomics initiatives, biobank infrastructure, and the EU In Vitro Diagnostic Regulation, which is shaping evidence expectations for diagnostic-grade assays. Latin America is advancing through Brazil and Mexico, where academic medicine, oncology research, infectious disease studies, and public health institutions support genomics adoption. The Middle East, led by Saudi Arabia, the UAE, and Qatar, is investing in precision medicine, population genomics, and national biobank programs, while Africa’s growth is anchored by South Africa, regional sequencing hubs, pathogen genomics capacity, and capacity-building programs such as H3Africa.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN is emerging as a practical growth corridor for miRNA assays, with Singapore providing advanced biomedical infrastructure and Thailand, Malaysia, Vietnam, Indonesia, and the Philippines expanding clinical research, molecular diagnostics, and academic sequencing capacity. GCC countries are investing in national health transformation programs, biobanks, genomic medicine, and precision oncology infrastructure, creating opportunities for liquid biopsy, non-coding RNA biomarker studies, and regulated assay development.

The European Union provides a mature regulatory and research environment where GDPR, IVDR, national genomics programs, and cross-border consortia influence assay validation, data governance, and clinical evidence generation. BRICS economies are important because China and India contribute scale in sequencing and biotechnology, Brazil and South Africa provide regional research leadership, and Russia maintains specialized biomedical research and bioinformatics capabilities. G7 countries concentrate extensive biopharma R&D, sequencing platform adoption, academic medical centers, and clinical validation expertise. NATO members are not a commercial bloc, but their emphasis on biosecurity, trusted data exchange, health-system resilience, and secure biotechnology infrastructure supports responsible deployment of advanced sequencing and diagnostic technologies.

Key Country Insights for miRNA Sequencing & Assay Adoption

The United States leads through NIH-supported genomics, cancer research networks, biopharma partnerships, FDA-regulated translational pathways, and advanced clinical laboratory infrastructure. Canada supports miRNA research through academic health systems, provincial genomics organizations, and national precision health programs, while Mexico is expanding genomics capacity through public institutions, oncology research, and cross-border scientific collaboration. Brazil is Latin America’s strongest base for sequencing-led biomedical research, supported by universities, public health expertise, population studies, and oncology-focused investigations.

In Europe, the United Kingdom benefits from national genomic medicine programs, NHS-linked research, biobank resources, and strong translational infrastructure. Germany and France combine pharmaceutical R&D, clinical research networks, academic sequencing centers, and advanced molecular diagnostics, while Italy and Spain are strengthening oncology, cardiovascular, neurodegenerative disease, and rare disease genomics. Russia maintains scientific capacity in molecular biology, computational biology, and specialized biomedical research. In Asia-Pacific, China provides scale in NGS, hospital-linked molecular research, and biomarker studies; India offers fast-growing biotechnology, clinical trial, and bioinformatics capacity; Japan emphasizes aging-related, oncology, and regenerative medicine applications; Australia supports translational genomics through national and state-level initiatives; and South Korea is advancing precision medicine through hospital-based sequencing, biobanking, and biopharma innovation.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize end-to-end workflow reliability, from sample collection and RNA extraction to sequencing, assay design, normalization, quality control, and reporting. miRNA measurements are highly sensitive to pre-analytical variables, so vendors and laboratories should provide validated protocols for plasma, serum, FFPE tissue, fresh tissue, extracellular vesicles, and low-input samples.

Organizations should also build assay portfolios that bridge discovery and clinical translation. Small RNA sequencing, qPCR panels, digital PCR, and multiplex assays should be positioned as complementary rather than competing technologies. Strategic investments in AI-enabled bioinformatics, external validation cohorts, regulatory evidence generation, reference materials, proficiency testing, and partnerships with biobanks, hospitals, and pharmaceutical sponsors will improve competitiveness. Leaders should also align product development with FDA, IVDR, CLIA, CAP, GDPR, ISO 15189, and local data protection requirements to accelerate adoption in clinical and regulated research settings.

Research Methodology

This executive summary is developed using a structured research methodology that combines secondary research, primary insight validation, and analytical triangulation. Secondary inputs include peer-reviewed literature on miRNA biology, small RNA sequencing, qPCR assays, digital PCR, extracellular vesicle analysis, biomarker discovery, clinical genomics, quality standards, and regulatory guidance. Publicly available information from government research agencies, genomics programs, standards organizations, clinical trial registries, and recognized biomedical databases is used to verify scientific and market context.

Primary validation typically includes inputs from sequencing service providers, assay developers, laboratory directors, clinical researchers, bioinformatics specialists, regulatory professionals, and commercial strategy leaders. Findings are triangulated by technology type, application area, end user, specimen type, region, and regulatory environment. Emphasis is placed on reproducible evidence, current scientific consensus, validated adoption patterns, and commercially relevant workflows rather than unverified projections.

Conclusion

The miRNA sequencing and assay market is moving toward higher clinical relevance as biomarker discovery, liquid biopsy research, oncology profiling, cardiovascular studies, neurodegenerative disease research, and precision medicine programs mature. Sequencing enables comprehensive discovery of known and novel microRNAs, while qPCR, digital PCR, and targeted panels support validation, quantification, and scalable testing. This technology stack is increasingly important for organizations seeking sensitive, minimally invasive molecular insights.

Future adoption will depend on standardization, analytical validation, AI-assisted interpretation, regulatory readiness, reference materials, and access to well-annotated clinical cohorts. Organizations that integrate reliable wet-lab workflows with transparent bioinformatics, validated assay performance, and region-specific commercialization strategies will be best positioned to capture demand across research, pharmaceutical, and clinical laboratory settings.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. miRNA Sequencing & Assay Market, by Product Type

7.1. Expression Assay Kit
7.1.1. Microarray Kit
7.1.2. Qrt-Pcr Kit
7.1.3. Sequencing Kit
7.2. Sequencing Platform
7.3. Services
7.3.1. Bioinformatics Services
7.3.2. Sequencing Services

8. miRNA Sequencing & Assay Market, by Technology

8.1. Microarray
8.2. Next Generation Sequencing
8.3. Rt-Qpcr

9. miRNA Sequencing & Assay Market, by Sample Type

9.1. Blood
9.2. Serum/Plasma
9.3. Tissue

10. miRNA Sequencing & Assay Market, by Application

10.1. Clinical Diagnostics
10.2. Disease Research
10.3. Drug Discovery

11. miRNA Sequencing & Assay Market, by End User

11.1. Academic Institutions
11.2. Contract Research Organizations
11.3. Hospitals & Diagnostic Laboratories
11.4. Pharmaceutical & Biotech

12. Asia-Pacific miRNA Sequencing & Assay Market
13. North America miRNA Sequencing & Assay Market
14. Latin America miRNA Sequencing & Assay Market
15. Europe miRNA Sequencing & Assay Market
16. Middle East miRNA Sequencing & Assay Market
17. Africa miRNA Sequencing & Assay Market
18. ASEAN miRNA Sequencing & Assay Market
19. GCC miRNA Sequencing & Assay Market
20. European Union miRNA Sequencing & Assay Market
21. BRICS miRNA Sequencing & Assay Market
22. G7 miRNA Sequencing & Assay Market
23. NATO miRNA Sequencing & Assay Market
24. United States miRNA Sequencing & Assay Market
25. Canada miRNA Sequencing & Assay Market
26. Mexico miRNA Sequencing & Assay Market
27. Brazil miRNA Sequencing & Assay Market
28. United Kingdom miRNA Sequencing & Assay Market
29. Germany miRNA Sequencing & Assay Market
30. France miRNA Sequencing & Assay Market
31. Russia miRNA Sequencing & Assay Market
32. Italy miRNA Sequencing & Assay Market
33. Spain miRNA Sequencing & Assay Market
34. China miRNA Sequencing & Assay Market
35. India miRNA Sequencing & Assay Market
36. Japan miRNA Sequencing & Assay Market
37. Australia miRNA Sequencing & Assay Market
38. South Korea miRNA Sequencing & Assay Market

39. Competitive Landscape

39.1. Market Concentration Analysis, 2025
39.1.1. Concentration Ratio (CR)
39.1.2. Herfindahl Hirschman Index (HHI)
39.2. Recent Developments & Impact Analysis, 2025
39.3. Product Portfolio Analysis, 2025
39.4. Benchmarking Analysis, 2025

40. Company Profiles

40.1. Agilent Technologies Inc
40.2. BGI Group
40.3. Bio-Rad Laboratories Inc
40.4. Eurofins Scientific
40.5. Fulgent Genetics Inc
40.6. GeneCopoeia Inc
40.7. HTG Molecular Diagnostics Inc
40.8. Illumina Inc
40.9. Lexogen GmbH
40.10. LGC Limited
40.11. Maravai LifeSciences
40.12. Merck KGaA
40.13. MGI Tech Co Ltd
40.14. Miltenyi Biotec B.V. & Co. KG
40.15. NeoGenomics Laboratories Inc
40.16. Norgen Biotek Corp
40.17. OriGene Technologies Inc
40.18. Oxford Nanopore Technologies PLC
40.19. Promega Corporation
40.20. Revvity Inc
40.21. SomaGenics Inc
40.22. System Biosciences LLC
40.23. Takara Bio Inc
40.24. Thermo Fisher Scientific Inc
40.25. Twist Bioscience Corporation
40.26. Vazyme Biotech Co Ltd

List of Figures

FIGURE 1. GLOBAL MIRNA SEQUENCING & ASSAY MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL MIRNA SEQUENCING & ASSAY MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL MIRNA SEQUENCING & ASSAY MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL MIRNA SEQUENCING & ASSAY MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 7. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 9. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 13. GLOBAL MIRNA SEQUENCING & ASSAY MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
FIGURE 14. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 15. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 17. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2032 (%)
FIGURE 19. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 21. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 23. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. ASIA-PACIFIC MIRNA SEQUENCING & ASSAY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 25. ASIA-PACIFIC MIRNA SEQUENCING & ASSAY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. NORTH AMERICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 27. NORTH AMERICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. LATIN AMERICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 29. LATIN AMERICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 30. EUROPE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 31. EUROPE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 32. MIDDLE EAST MIRNA SEQUENCING & ASSAY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 33. MIDDLE EAST MIRNA SEQUENCING & ASSAY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 34. AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 35. AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 36. ASEAN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 37. ASEAN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 38. GCC MIRNA SEQUENCING & ASSAY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 39. GCC MIRNA SEQUENCING & ASSAY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 40. EUROPEAN UNION MIRNA SEQUENCING & ASSAY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 41. EUROPEAN UNION MIRNA SEQUENCING & ASSAY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 42. BRICS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 43. BRICS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 44. G7 MIRNA SEQUENCING & ASSAY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 45. G7 MIRNA SEQUENCING & ASSAY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 46. NATO MIRNA SEQUENCING & ASSAY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 47. NATO MIRNA SEQUENCING & ASSAY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 48. UNITED STATES MIRNA SEQUENCING & ASSAY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 49. CANADA MIRNA SEQUENCING & ASSAY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 50. MEXICO MIRNA SEQUENCING & ASSAY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 51. BRAZIL MIRNA SEQUENCING & ASSAY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 52. UNITED KINGDOM MIRNA SEQUENCING & ASSAY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 53. GERMANY MIRNA SEQUENCING & ASSAY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 54. FRANCE MIRNA SEQUENCING & ASSAY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 55. RUSSIA MIRNA SEQUENCING & ASSAY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 56. ITALY MIRNA SEQUENCING & ASSAY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 57. SPAIN MIRNA SEQUENCING & ASSAY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 58. CHINA MIRNA SEQUENCING & ASSAY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 59. INDIA MIRNA SEQUENCING & ASSAY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 60. JAPAN MIRNA SEQUENCING & ASSAY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 61. AUSTRALIA MIRNA SEQUENCING & ASSAY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 62. SOUTH KOREA MIRNA SEQUENCING & ASSAY MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SHARE, BY KEY PLAYER, 2025
TABLE 7. GLOBAL MIRNA SEQUENCING & ASSAY MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
TABLE 8. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL EXPRESSION ASSAY KIT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL EXPRESSION ASSAY KIT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL EXPRESSION ASSAY KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL MICROARRAY KIT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL MICROARRAY KIT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL MICROARRAY KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL QRT-PCR KIT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL QRT-PCR KIT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL QRT-PCR KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL SEQUENCING KIT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL SEQUENCING KIT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL SEQUENCING KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL SEQUENCING PLATFORM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL SEQUENCING PLATFORM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL SEQUENCING PLATFORM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL BIOINFORMATICS SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL BIOINFORMATICS SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL BIOINFORMATICS SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL SEQUENCING SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL SEQUENCING SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL MICROARRAY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL MICROARRAY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL MICROARRAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL RT-QPCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL RT-QPCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL RT-QPCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL BLOOD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL BLOOD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL BLOOD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL SERUM/PLASMA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL SERUM/PLASMA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL SERUM/PLASMA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL TISSUE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL TISSUE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL TISSUE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL DISEASE RESEARCH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL DISEASE RESEARCH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL DISEASE RESEARCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL DRUG DISCOVERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL DRUG DISCOVERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL ACADEMIC INSTITUTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL ACADEMIC INSTITUTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL ACADEMIC INSTITUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL HOSPITALS & DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL HOSPITALS & DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL HOSPITALS & DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL PHARMACEUTICAL & BIOTECH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL PHARMACEUTICAL & BIOTECH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL PHARMACEUTICAL & BIOTECH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. ASIA-PACIFIC MIRNA SEQUENCING & ASSAY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. ASIA-PACIFIC MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 78. ASIA-PACIFIC MIRNA SEQUENCING & ASSAY MARKET SIZE, BY EXPRESSION ASSAY KIT, 2018-2032 (USD MILLION)
TABLE 79. ASIA-PACIFIC MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 80. ASIA-PACIFIC MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 81. ASIA-PACIFIC MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 82. ASIA-PACIFIC MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 83. ASIA-PACIFIC MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 84. NORTH AMERICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. NORTH AMERICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 86. NORTH AMERICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY EXPRESSION ASSAY KIT, 2018-2032 (USD MILLION)
TABLE 87. NORTH AMERICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 88. NORTH AMERICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 89. NORTH AMERICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 90. NORTH AMERICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 91. NORTH AMERICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 92. LATIN AMERICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. LATIN AMERICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 94. LATIN AMERICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY EXPRESSION ASSAY KIT, 2018-2032 (USD MILLION)
TABLE 95. LATIN AMERICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 96. LATIN AMERICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 97. LATIN AMERICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 98. LATIN AMERICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 99. LATIN AMERICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 100. EUROPE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. EUROPE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 102. EUROPE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY EXPRESSION ASSAY KIT, 2018-2032 (USD MILLION)
TABLE 103. EUROPE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 104. EUROPE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 105. EUROPE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 106. EUROPE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 107. EUROPE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 108. MIDDLE EAST MIRNA SEQUENCING & ASSAY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 109. MIDDLE EAST MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 110. MIDDLE EAST MIRNA SEQUENCING & ASSAY MARKET SIZE, BY EXPRESSION ASSAY KIT, 2018-2032 (USD MILLION)
TABLE 111. MIDDLE EAST MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 112. MIDDLE EAST MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 113. MIDDLE EAST MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 114. MIDDLE EAST MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 115. MIDDLE EAST MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 116. AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 117. AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 118. AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY EXPRESSION ASSAY KIT, 2018-2032 (USD MILLION)
TABLE 119. AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 120. AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 121. AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 122. AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 123. AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 124. ASEAN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 125. ASEAN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 126. ASEAN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY EXPRESSION ASSAY KIT, 2018-2032 (USD MILLION)
TABLE 127. ASEAN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 128. ASEAN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 129. ASEAN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 130. ASEAN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 131. ASEAN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 132. GCC MIRNA SEQUENCING & ASSAY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 133. GCC MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 134. GCC MIRNA SEQUENCING & ASSAY MARKET SIZE, BY EXPRESSION ASSAY KIT, 2018-2032 (USD MILLION)
TABLE 135. GCC MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 136. GCC MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 137. GCC MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 138. GCC MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 139. GCC MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 140. EUROPEAN UNION MIRNA SEQUENCING & ASSAY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 141. EUROPEAN UNION MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 142. EUROPEAN UNION MIRNA SEQUENCING & ASSAY MARKET SIZE, BY EXPRESSION ASSAY KIT, 2018-2032 (USD MILLION)
TABLE 143. EUROPEAN UNION MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 144. EUROPEAN UNION MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 145. EUROPEAN UNION MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 146. EUROPEAN UNION MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 147. EUROPEAN UNION MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 148. BRICS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 149. BRICS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 150. BRICS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY EXPRESSION ASSAY KIT, 2018-2032 (USD MILLION)
TABLE 151. BRICS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 152. BRICS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 153. BRICS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 154. BRICS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 155. BRICS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 156. G7 MIRNA SEQUENCING & ASSAY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 157. G7 MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 158. G7 MIRNA SEQUENCING & ASSAY MARKET SIZE, BY EXPRESSION ASSAY KIT, 2018-2032 (USD MILLION)
TABLE 159. G7 MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 160. G7 MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 161. G7 MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 162. G7 MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 163. G7 MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 164. NATO MIRNA SEQUENCING & ASSAY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 165. NATO MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 166. NATO MIRNA SEQUENCING & ASSAY MARKET SIZE, BY EXPRESSION ASSAY KIT, 2018-2032 (USD MILLION)
TABLE 167. NATO MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 168. NATO MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 169. NATO MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 170. NATO MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 171. NATO MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 172. UNITED STATES MIRNA SEQUENCING & ASSAY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 173. UNITED STATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 174. UNITED STATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY EXPRESSION ASSAY KIT, 2018-2032 (USD MILLION)
TABLE 175. UNITED STATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 176. UNITED STATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 177. UNITED STATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 178. UNITED STATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 179. UNITED STATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 180. CANADA MIRNA SEQUENCING & ASSAY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 181. CANADA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 182. CANADA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY EXPRESSION ASSAY KIT, 2018-2032 (USD MILLION)
TABLE 183. CANADA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 184. CANADA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 185. CANADA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 186. CANADA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 187. CANADA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 188. MEXICO MIRNA SEQUENCING & ASSAY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 189. MEXICO MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 190. MEXICO MIRNA SEQUENCING & ASSAY MARKET SIZE, BY EXPRESSION ASSAY KIT, 2018-2032 (USD MILLION)
TABLE 191. MEXICO MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 192. MEXICO MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 193. MEXICO MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 194. MEXICO MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 195. MEXICO MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 196. BRAZIL MIRNA SEQUENCING & ASSAY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 197. BRAZIL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 198. BRAZIL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY EXPRESSION ASSAY KIT, 2018-2032 (USD MILLION)
TABLE 199. BRAZIL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 200. BRAZIL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 201. BRAZIL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 202. BRAZIL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 203. BRAZIL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 204. UNITED KINGDOM MIRNA SEQUENCING & ASSAY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 205. UNITED KINGDOM MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 206. UNITED KINGDOM MIRNA SEQUENCING & ASSAY MARKET SIZE, BY EXPRESSION ASSAY KIT, 2018-2032 (USD MILLION)
TABLE 207. UNITED KINGDOM MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 208. UNITED KINGDOM MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 209. UNITED KINGDOM MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 210. UNITED KINGDOM MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 211. UNITED KINGDOM MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 212. GERMANY MIRNA SEQUENCING & ASSAY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 213. GERMANY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 214. GERMANY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY EXPRESSION ASSAY KIT, 2018-2032 (USD MILLION)
TABLE 215. GERMANY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 216. GERMANY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 217. GERMANY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 218. GERMANY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 219. GERMANY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 220. FRANCE MIRNA SEQUENCING & ASSAY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 221. FRANCE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 222. FRANCE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY EXPRESSION ASSAY KIT, 2018-2032 (USD MILLION)
TABLE 223. FRANCE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 224. FRANCE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 225. FRANCE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 226. FRANCE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 227. FRANCE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 228. RUSSIA MIRNA SEQUENCING & ASSAY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 229. RUSSIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 230. RUSSIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY EXPRESSION ASSAY KIT, 2018-2032 (USD MILLION)
TABLE 231. RUSSIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 232. RUSSIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 233. RUSSIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 234. RUSSIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 235. RUSSIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 236. ITALY MIRNA SEQUENCING & ASSAY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 237. ITALY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 238. ITALY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY EXPRESSION ASSAY KIT, 2018-2032 (USD MILLION)
TABLE 239. ITALY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 240. ITALY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 241. ITALY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 242. ITALY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 243. ITALY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 244. SPAIN MIRNA SEQUENCING & ASSAY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 245. SPAIN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 246. SPAIN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY EXPRESSION ASSAY KIT, 2018-2032 (USD MILLION)
TABLE 247. SPAIN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 248. SPAIN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 249. SPAIN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 250. SPAIN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 251. SPAIN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 252. CHINA MIRNA SEQUENCING & ASSAY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 253. CHINA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 254. CHINA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY EXPRESSION ASSAY KIT, 2018-2032 (USD MILLION)
TABLE 255. CHINA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 256. CHINA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 257. CHINA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 258. CHINA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 259. CHINA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 260. INDIA MIRNA SEQUENCING & ASSAY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 261. INDIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 262. INDIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY EXPRESSION ASSAY KIT, 2018-2032 (USD MILLION)
TABLE 263. INDIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 264. INDIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 265. INDIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 266. INDIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 267. INDIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 268. JAPAN MIRNA SEQUENCING & ASSAY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 269. JAPAN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 270. JAPAN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY EXPRESSION ASSAY KIT, 2018-2032 (USD MILLION)
TABLE 271. JAPAN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 272. JAPAN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 273. JAPAN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 274. JAPAN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 275. JAPAN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 276. AUSTRALIA MIRNA SEQUENCING & ASSAY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 277. AUSTRALIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 278. AUSTRALIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY EXPRESSION ASSAY KIT, 2018-2032 (USD MILLION)
TABLE 279. AUSTRALIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 280. AUSTRALIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 281. AUSTRALIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 282. AUSTRALIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 283. AUSTRALIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 284. SOUTH KOREA MIRNA SEQUENCING & ASSAY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 285. SOUTH KOREA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 286. SOUTH KOREA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY EXPRESSION ASSAY KIT, 2018-2032 (USD MILLION)
TABLE 287. SOUTH KOREA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 288. SOUTH KOREA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 289. SOUTH KOREA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 290. SOUTH KOREA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 291. SOUTH KOREA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The companies featured in this miRNA Sequencing & Assay market report include:

Agilent Technologies Inc
BGI Group
Bio-Rad Laboratories Inc
Eurofins Scientific
Fulgent Genetics Inc
GeneCopoeia Inc
HTG Molecular Diagnostics Inc
Illumina Inc
Lexogen GmbH
LGC Limited
Maravai LifeSciences
Merck KGaA
MGI Tech Co Ltd
Miltenyi Biotec B.V. & Co. KG
NeoGenomics Laboratories Inc
Norgen Biotek Corp
OriGene Technologies Inc
Oxford Nanopore Technologies PLC
Promega Corporation
Revvity Inc
SomaGenics Inc
System Biosciences LLC
Takara Bio Inc
Thermo Fisher Scientific Inc
Twist Bioscience Corporation
Vazyme Biotech Co Ltd

Table Information

Report Attribute	Details
No. of Pages	199
Published	June 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 502.41 Million
Forecasted Market Value ( USD ) by 2032	$ 1120 Million
Compound Annual Growth Rate	14.5%
Regions Covered	Global
No. of Companies Mentioned	27

License	Format	Properties	Price
1 - 5 USER LICENSE PDF, Excel and Online Access		This is a 1-5 user license, allowing up to five users have access to the product.	€3211EUR$3,545USD£2,770GBP €3568EUR$3,939USD£3,078GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€4858EUR$5,363USD£4,191GBP €5398EUR$5,959USD£4,657GBP

miRNA Sequencing & Assay Market by Product Type, Technology, Sample Type, Application, End User - Global Forecast 2026-2032

Transformative Shifts in the miRNA Sequencing Landscape

Cumulative Impact of Artificial Intelligence on miRNA Analysis

Key Regional Insights for miRNA Sequencing & Assays

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

Key Country Insights for miRNA Sequencing & Assay Adoption

Actionable Recommendations for Industry Leaders

Research Methodology

Conclusion

Table of Contents

Companies Mentioned

Table Information

Transformative Shifts in the miRNA Sequencing Landscape

Cumulative Impact of Artificial Intelligence on miRNA Analysis

Key Regional Insights for miRNA Sequencing & Assays

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

Key Country Insights for miRNA Sequencing & Assay Adoption

Actionable Recommendations for Industry Leaders

Research Methodology

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

miRNA Sequencing and Assay Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

MiRNA Sequencing and Assay Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

miRNA Sequencing and Assays - Global Strategic Business Report

Mirna Sequencing and Assay Market Outlook 2026-2034: Market Share and Growth Analysis by Product (Sequencing Consumables, Library Preparation Kits, Sequencing Platforms / Instruments, Bioinformatics Pipelines & Services), Technology, Application, End User

MicroRNA Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)